Interferon-α(2b) therapy is efficacious in Asian-Americans with chronic hepatitis B infection: A prospective controlled trial

Digestive Diseases and Sciences

Volumn 43, Issue 4, 1998, Pages 875-879

  Martin, Paul ^a   Hann, Hie Won ^b   Westerberg, Sharon ^b   Muñoz, Santiago J ^b   Rubin, Raphael ^b   Maddrey, Willis C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Asians; Chronic hepatitis B; Interferon; Prednisone

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA; ALPHA2B INTERFERON; ANTIVIRUS AGENT;

ADULT; ARTICLE; ASIAN AMERICAN; CAUCASIAN; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS REPLICATION; BLOOD; ETHNOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASIAN AMERICANS; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; PREDNISONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 0031596619     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018894804569     Document Type: Article

References (25)

1. Beasley RP: Hepatitis B virus as the etiologic agent in hepatocellular carcinoma epidemiologies considerations. Hepatology 2:215-265, 1982
2. Tong MJ, Hwang SJ: Hepatitis B virus infection in Asian Americans. Gastroenterol Clin N Am 23:523-536, 1994
3. 2b alone and after prednisone withdrawal in the treatment of chronic hepatitis B infection. N Engl J Med 323:295-301, 1990
4. Hoofnagle JH, Peters M, Mullen KD, et al: Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 95:1318-1325, 1988
5. Fevery J, Elewaut A, Michelsen P, Nevens F, Van Eyken P, Adler M, Desmet V: Efficacy of interferon alpha-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double blind Belgian-Dutch Study. J Hepatol 11:8108-8112, 1990
6. Reichen J, Bianchi L, Frei PC, Malé PJ, Lavanchy D, Schmid M, Swiss Association for the Study of the Liver: Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B: Results of a randomized multicenter trial. J Hepatol 20:168-174, 1994
7. Carreno V, Castillo I, Molina J, Porres JC, Barbolomé J: Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 15:102-106, 1992
8. Korenman J, Baker B, Waggoner J, et al: Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 115:113-115, 1991
9. Lai CL, Lok ASF, Wu PC, et al: Placebo controlled trial of recombinant alpha-interferon in Chinese HBsAg-carrier children. Lancet 2:877-880, 1987
10. Lai CL, Lin HJ, Lau JYN, Flok AS, Wu PC, Chung HT, Wong LSK, Leung MP, Yeung CY: Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 286:155-163, 1991
11. Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, Ma OCK, Lauder IJ, Ng CPL, Chung HT: A controlled trial of interferon therapy with or without prednisone therapy for chronic hepatitis B. Gastroenterology 102:2091-2097, 1992
12. Liaw YF, Lin SM, Chen TJ, Chien RN, Sheen IS, Chu CM: Beneficial effect of prednisone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. J Hepatol 20:175-180, 1994
13. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657-1661, 1995
14. Gonzalez-Mateos F, Garcia-Monzon C, Garcia-Buey L, Garcia A, Pajares JM, Moreno-Otero R: Long term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature. Hepato-Gastroenterology 42:893-899, 1995
15. Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Haussinger D: Long-term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitis B. N Engl J Med 334:1422-1427, 1996
16. Fattovich G, Brollo L, Alberti A, et al: Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. J Hepatol 11:29-33, 1990
17. Brook MG, Main J, Yap I, Chan G, Karayiannis P, Crossey M, Thomas HC: Short Report: Prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection. Aliment Pharmacol Ther 7:331-336, 1993
18. Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moren A, Garcia-Aguado J, Carreno V: Prospective, randomized controlled trial of interferon alpha in children with chronic hepatitis B. Hepatology 13:1035-1039, 1991
19. Utili R, Sagnelli E, Gaeta GB, Galanti B, Nordiello S, Felaco FM, Pasquale G, Marrone A, Aprea L, Pizzella T, Digilio L, Cesaro G, Sardano C, Santarpia L, Adinolfi LE, Andreona A, Russo M, Filippini P, Zampino R, Piccinno F, Ruggierro G, Giusti G: Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: A controlled randomized study. J Hepatol 20:163-167, 1994
20. Barbera C, Bortolotti F, Crivelloro C, Coscia A, Zancan L, Cadrobbi P, Neblia G, Pillon MN, Lepare L, Parrella T, Dastoli G, Brunetto MR, Bonino F: Recombinant interferon alpha-2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 20:287-290, 1994
21. Gregorio GV, Jara P, Hierro L, Diaz C, de la Vega A, Vegnente A, Torio R, Bortolotti F, Crivellaro C, Zancan L, Daniels H, Portmann B, Mieli-Vergass G: Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial. Hepatology 23:700-707, 1996
22. Perrillo RP: Interferon in the management of chronic hepatitis B. Dig Dis Sci 38:577-593, 1993
23. Lok ASF, Chung HT, Liu VWS, Ma OCK: Long-term follow-up of chronic hepatitis B patients treated with interferon alpha. Gastroenterology 105:1833-1838, 1993
24. Lok ASF, Lai CL, Wu PC, et al: Spontaneous hepatitis B e antigen to antibody conversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92:1839-1843, 1987
25. Lai CL, Ching CK, Tung ANM, Li E, Young J, Hill A, Wong BCY: Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial. Hepatology 25:241-244, 1997